NICHOLA LINAMEN: Open Payments
NPI 1265916944 · SANTA ANA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$250 in 6 payments from 5 companies in 2025. Trend: 2023 $24 · 2024 $433 · 2025 $250
Food & beverage: $250
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 1 | $126 |
| GENZYME CORPORATION | 1 | $50 |
| AstraZeneca Pharmaceuticals LP | 2 | $29 |
| Janssen Pharmaceuticals, Inc | 1 | $27 |
| Merck Sharp & Dohme LLC | 1 | $17 |
Products named: DUPIXENT, AIRSUPRA, SPRAVATO, CAPVAXIVE.
Industry payments across CA — which companies pay providers there.
